The main objectives of this study are to characterize GLUT-1 expression in breast cancer in diabetic and obese patients compared to non-diabetic and non-obese patients, and to compare histological and prognostic factors between these three groups. This evidence concerns the gene SLC2A1 and breast carcinoma.